| ID | Name | CAS | Properties |
Tfus (K) |
| 125-242-4 |
Succinic acid, 3,4-dimethylphenyl 2,2,3,3,4,4,4-heptafluorobutyl ester
|
|
6 | 300.00 |
| 125-254-1 |
10H-Phenothiazin-3-ol, 10-[3-(dimethylamino)propyl]-, acetate (ester)
|
56438-23-4 |
6 | 405.86 |
| 10-629-2 |
1,8-Diaza-tricyclo[7.6.0.0*3,7*]pentadeca-3(7),8-dien-2-one
|
|
5 | 463.00 |
| 10-906-4 |
Silane, [[(16«beta»,17«alpha»)-estra-1,3,5(10)-triene-3,16,17-triyl]tris(oxy)]tris[trimethyl-
|
57305-22-3 |
5 | 369.99 |
| 11-272-7 |
allo-Cholanic acid, 3«alpha»,12«alpha»-dihydroxy, Me-TMS
|
|
5 | 365.70 |
| 11-342-9 |
7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-
|
484-20-8 |
5 | 461.15 |
| 11-470-7 |
Bicyclo[2.2.1]hept-2-ene, 5-(bromomethyl)-1,2,3,4,7,7-hexachloro-
|
|
5 | 350.15 |
| 12-819-9 |
Silane, (estra-1,3,5(10)-trien-3-yloxy)trimethyl-
|
29755-24-6 |
5 | 369.90 |
| 12-961-1 |
allo-Cholanic acid, 3«alpha»,12«alpha»-dihydroxy, Me-DMES
|
|
5 | 351.77 |
| 13-662-2 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-(1-methylbutyl)-5-(2-propenyl)-
|
28239-49-8 |
5 | 303.10 |
| 13-737-9 |
Benzoic acid, 2-[[ethoxy[(1-methylethyl)amino]phosphinothioyl]oxy]-, 1-methylethyl ester
|
|
5 | 261.15 |
| 16-153-4 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1,3-dimethyl-5-(3-methylbutyl)-
|
28239-46-5 |
5 | 334.70 |
| 16-182-2 |
Cholan-24-oic acid, 3-[(trimethylsilyl)oxy]-, methyl ester, (3«alpha»,5«beta»)-
|
59953-47-8 |
5 | 379.97 |
| 16-203-8 |
1H-1,2,4-Triazole-1-ethanol, «beta»-[(2,4-dichlorophenyl)methylene]-«alpha»-(1,1-dimethylethyl)-,(E)-(±)-
|
|
5 | 351.16 |
| 16-439-7 |
allo-Cholanic acid, 3«alpha»,7«alpha»-dihydroxy, Me-DMES
|
|
5 | 368.17 |
| 16-807-8 |
Estra-1,3,5(10)-trien-17-one, 3-[(trimethylsilyl)oxy]-
|
|
5 | 394.56 |
| 16-851-9 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1,3-dimethyl-5-(1-methylbutyl)-
|
28239-47-6 |
5 | 320.79 |
| 17-350-4 |
benzaldehyde oxime, 2-hydroxy, 5-(1,1,3,3-tetramethylbutyl)
|
|
5 | 419.34 |
| 18-200-9 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,3-dimethyl-butyl)-amine
|
|
5 | 351.74 |
| 18-293-7 |
2-Propen-1-ol, 3-(4-hydroxy-3-methoxyphenyl), bis-TMS
|
|
5 | 326.97 |
| 18-402-5 |
Silane, dimethyl(dimethyl(3-phenylpro-2-enyloxy)silyloxy)(3-phenylpro-2-enyloxy)-
|
|
5 | 306.37 |
| 18-577-2 |
Trimethylsilyl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitro-benzoate
|
|
5 | 357.39 |
| 19-607-7 |
1,3,5(10)-Oestratriene-3,17«beta»-diol, 3-TMS-17-HFB
|
|
5 | 372.29 |
| 20-539-1 |
4-(«alpha»-Ethyl-5-phenyl-1H-pyrrol-3-yl)-pyridine
|
|
5 | 418.02 |
| 21-578-7 |
6-Chloro-N-sec-butyl-1,3,5-triazine-2,4-diamine
|
37019-18-4 |
5 | 399.92 |
| 22-982-7 |
2-Methyl-2-p-toluenesulfonylamino-1,3-propanediol acetate p-toluenesulfonate
|
|
5 | 373.72 |
| 23-353-4 |
6-Chloro-N,N'-(cyclopentyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | 435.28 |
| 23-744-0 |
1,4-Butanediamine, n-(3-aminopropyl)-, phosphate (1 to 1)
|
|
5 | 394.93 |
| 23-872-8 |
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-
|
20971-53-3 |
5 | 416.53 |
| 23-943-9 |
Morphinan, 7,8-didehydro-4,5-epoxy-17-methyl-3,6-bis[(trimethylsilyl)oxy]-, (5«alpha»,6«alpha»)-
|
55449-66-6 |
5 | 367.35 |
| 25-279-5 |
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-
|
|
5 | 623.15 |
| 26-296-5 |
1H-Indole, 2,3-dihydro-1,3,3-trimethyl-2-methylene-
|
118-12-7 |
5 | 263.15 |
| 26-988-7 |
6H-Purin-6-one, 2-amino-1,7-dihydro-7-methyl-
|
|
5 | 643.15 |
| 27-565-5 |
3H-Pyrido(3,4-b)indole, 4,9-dihydro-6-methoxy-1-methyl-
|
3589-73-9 |
5 | 446.04 |
| 28-206-2 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-diethyl-5-(1-methylbutyl)-5-(2-propenyl)-
|
54833-76-0 |
5 | 299.65 |
| 28-564-5 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1,3,5-trimethyl-
|
726-79-4 |
5 | 356.74 |
| 29-126-0 |
5,6-Dihydro-5-methyl-4H-1,3,5-dithiazine
|
|
5 | 338.15 |
| 30-384-2 |
allo-Cholanic acid, 3«beta»,7«beta»-dihydroxy, Me-TMS
|
|
5 | 382.39 |
| 30-795-6 |
3,16,17-Tris[(trimethylsilyl)oxy]estra-1,3,5(10)-triene, (16«beta»,17«beta»)-
|
57305-21-2 |
5 | 369.99 |
| 31-755-9 |
Silane, dimethyl(dimethyl(2-chloro-5-methylphenoxy)silyloxy)(2-chloro-5-methylphenoxy)-
|
|
5 | 340.97 |
| 32-504-6 |
7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-E][1,5]diazocin-6-one, dodecahydro-, [7R-(7«alpha»,7a«alpha»,14«alpha»,14a«beta»)]-
|
489-72-5 |
5 | 384.15 |
| 34-181-3 |
1H-Pyrrole-3-carboxylic acid, 2,4-dimethyl-, methyl ester
|
|
5 | 335.56 |
| 34-250-6 |
5-(4-Chlorophenyl)-6-ethylpyrimidine-2,4-diamine, N,N'-bis(trifluoroacetyl)-
|
|
5 | 481.31 |
| 34-424-3 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1,3-dimethyl-5-(1-methylpropyl)-
|
55134-03-7 |
5 | 339.09 |
| 35-361-2 |
3-Amino-2,5-dichlorobenzoic acid, N-dimethylaminomethylene-, methyl ester
|
|
5 | 354.94 |
| 37-407-9 |
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-6-(trimethylsilyl)-, (5«alpha»,6«alpha»)-
|
|
5 | 375.41 |
| 38-066-7 |
Aluminum, tris(1,1,1-trifluoro-2,4-pentanedionato-O,O')-
|
14354-59-7 |
5 | 432.61 |
| 39-106-1 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-bis-(chloromethyl), 1,3-bis-(4-methoxyphenyl))
|
|
5 | 323.36 |
| 39-682-2 |
allo-Cholanic acid, 3«beta»,12«beta»-dihydroxy, Me-TMS
|
|
5 | 365.70 |
| 39-806-4 |
allo-Cholanic acid, 3«beta»,12«alpha»-dihydroxy, Me-TMS
|
|
5 | 365.70 |
| 39-893-8 |
5«beta»-Androstan-3«alpha»-ol-17-one (Etiocholanolone), MO
|
|
5 | 405.62 |
| 40-260-8 |
allo-Cholanic acid, 3«alpha»,12«beta»-dihydroxy, Me-TMS
|
|
5 | 365.70 |
| 40-271-6 |
2H-Furo[2,3-h]-1-benzopyran-2-one, 5-methoxy-
|
482-48-4 |
5 | 427.94 |
| 40-395-9 |
Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid, 1,4,5,6,7,7-hexachloro-
|
|
5 | 497.90 |
| 40-952-0 |
Phosphoric acid, dimethyl 1-methyl-3-(methylamino)-3-oxo-1-propenyl ester, (Z)-
|
919-44-8 |
5 | 307.39 |
| 40-956-6 |
2-Imidazolidinone, 3-[5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl]-4-hydroxy-1-methyl-
|
55511-98-3 |
5 | 410.42 |
| 41-365-1 |
2-Hydroxymethyl-3-(o-tolyl)-4(3H)-quinazolinone (Methaqualone M)
|
|
5 | 425.32 |
| 41-929-5 |
1,3,5(10)-Oestratriene-3,17«beta»-diol, 3-TMS-17-PFP
|
|
5 | 377.21 |
| 42-757-5 |
1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 3-(3-butenyl)-1,2,3,4,5,6-hexahydro-, (1R)-
|
529-78-2 |
5 | 344.24 |
| 43-321-7 |
3H-1,4-Benzodiazepine, 2-amino-7-chloro-5-phenyl-, 4-oxide
|
7722-15-8 |
5 | 492.01 |
| 43-898-8 |
1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-1,3-dimethyl-
|
944-73-0 |
5 | 582.89 |
| 44-273-0 |
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-
|
50-35-1 |
5 | 543.15 |
| 44-618-7 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-E][1,5]diazocin-4-one, 7,7a,8,9,10,11,13,14-octahydro-, [7R-(7«alpha»,7a«alpha»,14«alpha»)]-
|
486-90-8 |
5 | 399.69 |
| 44-918-4 |
2-Butanol, 4-dimethylamino-3-methyl-1,2-diphenyl-, propionate
|
77-50-9 |
5 | 348.40 |
| 44-963-4 |
1,3-Dioxolo[4,5-g]isoquinolin-5-ol, 5,6,7,8-tetrahydro-6-methyl-
|
6592-85-4 |
5 | 414.16 |
| 45-530-3 |
(1E,2e)-1,3-bis(4-chlorophenyl)-2-buten-1-one oxime
|
30542-21-3 |
5 | 375.66 |
| 47-719-2 |
1,3,6,8-Tetraazatricyclo[4.4.1.1(3,8)]dodecane
|
|
5 | 531.17 |
| 50-109-5 |
2H-1-Benzopyran-2-one, 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthalenyl)-
|
5836-29-3 |
5 | 445.15 |
| 50-544-2 |
2H-Pyran-2-carboxaldehyde, 3,4-dihydro-2,5-dimethyl-
|
|
5 | 209.00 |
| 50-933-0 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,1-dimethyl-butyl)-amine
|
|
5 | 376.09 |
| 53-503-4 |
Methyl 17A-hydroxy-3-oxoandrost-4-ene-17B-carboxylate, 3-MO
|
|
5 | 439.96 |
| 57-129-6 |
2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-dimethyl-
|
|
5 | 379.15 |
| 57-247-5 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohepten-1-yl)-5-ethyl-1,3-dimethyl-
|
|
5 | 364.10 |
| 57-861-3 |
1H-3a,7-Methanoazulene, octahydro-3,6,8,8-tetramethyl-, [3R-(3«alpha»,3a«beta»,6«alpha»,7«beta»,8a«alpha»)]-
|
13567-54-9 |
5 | 301.40 |
| 59-197-9 |
2,7-Dimethylbenzo-[1,2-d,5,4-d]bisoxazole
|
|
5 | 477.63 |
| 59-998-0 |
(Z)-N-tert-Butyldimethylsilyloxy-1-(4-methoxy-3-nitro-phenyl)ethanimine
|
|
5 | 383.29 |
| 60-022-0 |
1H-Purine-2,6-dione, 7-ethyl-3,7-dihydro-1,3-dimethyl-
|
23043-88-1 |
5 | 465.00 |
| 60-676-5 |
4-Methyl-2-phenyl-1,2,3-triazole-5-carboxylic acid
|
|
5 | 476.15 |
| 60-680-0 |
5«alpha»-Androstan-3«alpha»-ol-17-one (Androsterone), MO
|
|
5 | 405.62 |
| 61-695-3 |
allo-Cholanic acid, 3«alpha»,12«beta»-dihydroxy, Me-DMES
|
|
5 | 351.77 |
| 61-719-6 |
2H-Pyran-2-one, 5,6-dihydro-3,5,5-trimethyl-
|
74793-10-5 |
5 | 298.60 |
| 61-929-3 |
O,O-Diethyl-S-(1,1-difluoro-2-chloroethyl)-dithiophosphate
|
|
5 | 236.97 |
| 62-710-4 |
7H-furo[3,2-g][1]benzopyran-7-one, 9-[(3-methyl-2-butenyl)oxy]-
|
|
5 | 385.48 |
| 63-797-8 |
[1,1'-Biphenyl]-2-yl 4-tert-butylphenyl phenyl phosphate
|
|
5 | 352.93 |
| 63-871-5 |
(E)-N-tert-Butyldimethylsilyloxy-1-(4-methoxy-3-nitrophenyl)ethanimine
|
|
5 | 383.29 |
| 64-392-6 |
[1,3,5]Triazine-2,4-diamine, 6-chloro-N,N'-dicycloheptyl-
|
|
5 | 446.64 |
| 65-887-6 |
allo-Cholanic acid, 3«beta»,7«beta»-dihydroxy, Me-DMES
|
|
5 | 368.17 |
| 66-373-5 |
6-Chloro-N,N'-(1,1,3,3-tetramethylbutyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | 468.72 |
| 66-572-4 |
3«beta»,7«beta»-Dihydroxy-5«beta»-cholanoic acid, MeTMS
|
78964-21-3 |
5 | 382.39 |
| 66-573-3 |
allo-Cholanic acid, 3«alpha»,7«beta»-dihydroxy, Me-TMS
|
|
5 | 382.39 |
| 66-574-2 |
allo-Cholanic acid, 3«beta»,7«alpha»-dihydroxy, Me-TMS
|
|
5 | 382.39 |
| 66-575-1 |
allo-Cholanic acid, 3«alpha»,7«alpha»-dihydroxy, Me-TMS
|
|
5 | 382.39 |
| 67-979-2 |
Bicyclo[2.2.2]-7-octene-2,3,5,6-tetracarboxylic acid dianhydride
|
1719-83-1 |
5 | 633.15 |
| 68-400-2 |
3H-Pyrimidin-4-one, 2,3:5,6-bis-trimethyleno
|
|
5 | 453.16 |
| 68-568-7 |
1H-2«lambda»*6*-Benzo[2,1,3]thiadiazin-4-one, 3-isopropyl-2,2-dioxo-2,3-dihydro
|
|
5 | 486.13 |
| 68-651-4 |
1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-
|
28822-58-4 |
5 | 473.65 |
| 69-782-8 |
allo-Cholanic acid, 3«alpha»,7«beta»-dihydroxy, Me-DMES
|
|
5 | 368.17 |
| 69-783-7 |
allo-Cholanic acid, 3«beta»,7«alpha»-dihydroxy, Me-DMES
|
|
5 | 368.17 |
| 70-017-5 |
allo-Cholanic acid, 3«beta»,12«alpha»-dihydroxy, Me-DMES
|
|
5 | 351.77 |
| 70-018-4 |
allo-Cholanic acid, 3«beta»,12«beta»-dihydroxy, Me-DMES
|
|
5 | 351.77 |
|
« Previous Results
Next Results »
|